<VariationArchive RecordType="classified" VariationID="11546" VariationName="NM_004208.4(AIFM1):c.603_605del (p.Arg201del)" VariationType="Deletion" Accession="VCV000011546" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-10" DateCreated="2016-09-21" MostRecentSubmission="2016-09-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26585" VariationID="11546">
      <GeneList>
        <Gene Symbol="AIFM1" FullName="apoptosis inducing factor mitochondria associated 1" GeneID="9131" HGNC_ID="HGNC:8768" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq26.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="130129362" stop="130165841" display_start="130129362" display_stop="130165841" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="129263336" stop="129299860" display_start="129263336" display_stop="129299860" Strand="-" />
          </Location>
          <OMIM>300169</OMIM>
        </Gene>
        <Gene Symbol="RAB33A" FullName="RAB33A, member RAS oncogene family" GeneID="9363" HGNC_ID="HGNC:9773" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq26.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="130110623" stop="130184870" display_start="130110623" display_stop="130184870" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="129305772" stop="129318843" display_start="129305772" display_stop="129318843" Strand="+" />
          </Location>
          <OMIM>300333</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004208.4(AIFM1):c.603_605del (p.Arg201del)</Name>
      <CanonicalSPDI>NC_000023.11:130147492:CTTCT:CT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="130147493" stop="130147495" display_start="130147493" display_stop="130147495" variantLength="3" positionVCF="130147492" referenceAlleleVCF="CCTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="129281468" stop="129281470" display_start="129281468" display_stop="129281470" variantLength="3" positionVCF="129281467" referenceAlleleVCF="CCTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>R201del</ProteinChange>
      <ProteinChange>R197del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.129281470_129281472del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.129281470_129281472del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.130147495_130147497del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.130147495_130147497del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013217.1" sequenceAccession="NG_013217" sequenceVersion="1" change="g.23339_23341del">
            <Expression>NG_013217.1:g.23339_23341del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130847.4" sequenceAccession="NM_001130847" sequenceVersion="4" change="c.603_605del">
            <Expression>NM_001130847.4:c.603_605del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124319.1" sequenceAccession="NP_001124319" sequenceVersion="1" change="p.Arg201del">
            <Expression>NP_001124319.1:p.Arg201del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004208.4" sequenceAccession="NM_004208" sequenceVersion="4" change="c.603_605del" MANESelect="true">
            <Expression>NM_004208.4:c.603_605del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004199.1" sequenceAccession="NP_004199" sequenceVersion="1" change="p.Arg201del">
            <Expression>NP_004199.1:p.Arg201del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145812.3" sequenceAccession="NM_145812" sequenceVersion="3" change="c.591_593del">
            <Expression>NM_145812.3:c.591_593del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_665811.1" sequenceAccession="NP_665811" sequenceVersion="1" change="p.Arg197del">
            <Expression>NP_665811.1:p.Arg197del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_132647.2" sequenceAccession="NR_132647" sequenceVersion="2" change="n.645_647del">
            <Expression>NR_132647.2:n.645_647del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA121542" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300169.0001" DB="OMIM" />
        <XRef Type="rs" ID="387906500" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004208.4(AIFM1):c.603_605del (p.Arg201del) AND Severe X-linked mitochondrial encephalomyopathy" Accession="RCV000012302" Version="24">
        <ClassifiedConditionList TraitSetID="3151">
          <ClassifiedCondition DB="MedGen" ID="C3151753">Severe X-linked mitochondrial encephalomyopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-04-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2010-04-09" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-09-21" MostRecentSubmission="2016-09-21">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20362274</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3151" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6671" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Severe X-linked mitochondrial encephalomyopathy</ElementValue>
                <XRef ID="MONDO:0010437" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ENCEPHALOMYOPATHY, MITOCHONDRIAL, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="300816" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Combined oxidative phosphorylation deficiency 6</ElementValue>
                <XRef ID="Combined+oxidative+phosphorylation+deficiency+6/8018" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">COXPD6</ElementValue>
                <XRef Type="MIM" ID="300816" DB="OMIM" />
              </Symbol>
              <XRef ID="238329" DB="Orphanet" />
              <XRef ID="C3151753" DB="MedGen" />
              <XRef ID="MONDO:0010437" DB="MONDO" />
              <XRef Type="MIM" ID="300816" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32536" SubmissionDate="2016-09-19" DateLastUpdated="2016-09-21" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300169.0001_COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6" title="AIFM1, 3-BP DEL, 601AGA_COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6" />
        <ClinVarAccession Accession="SCV000032536" DateUpdated="2016-09-21" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-04-09">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 Italian male first-cousins, born of monozygotic twin sisters and unrelated fathers, with combined oxidative phosphorylation deficiency resulting in a severe mitochondrial encephalomyopathy (COXPD6; 300816), Ghezzi et al. (2010) identified a hemizygous 3-bp deletion (601delAGA) in the AIFM1 gene, resulting in the deletion of arg201. Both had onset in the first year of life of psychomotor regression, muscle weakness and atrophy, lack of further development, and abnormal signals in the basal ganglia. One died at age 16 months, and the other was tetraplegic and wheelchair-bound with an inability to communicate at age 5 years. In silico analysis indicated that arg201 residue is part of a hairpin that forms the FAD-binding pouch and confers conformational stability to the flavoprotein. Thus, deletion of arg201 probably perturbs the functional properties of both oxidized and reduced forms of AIF. In vitro studies showed that the lifetime of the FADH2-NAD complex formed by mutant mitochondrial AIF was shorter than that observed with wildtype. The mutant protein also had increased susceptibility to proteolytic cleavage, indicating that it is a structurally unstable variant. The mutant protein also showed higher DNA binding affinity and potential ability to cause DNA damage compared to wildtype. Approximately 75% of mutant cells versus 23% of control cells showed mitochondrial fragmentation under galactose treatment, suggesting that cells containing the mutant are more sensitive to apoptotic stimuli than control cells. Mitochondrial fragmentation was associated with impaired oxidative phosphorylation. Riboflavin treatment of cells with the mutant protein showed a recovery of the filamentous network and improvement in cell viability, which corresponded to some clinical improvement seen in 1 of the patients with the mutation. Overall, the studies showed that the AIFM1 mutation resulted in destabilization of the inner mitochondrial membrane with subsequent damage to respiratory chain structure and activities. In addition, the mutation resulted in impaired control of mitochondrion-derived programmed cell death.</Attribute>
              <Citation>
                <ID Source="PubMed">20362274</ID>
              </Citation>
              <XRef DB="OMIM" ID="300816" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AIFM1" />
          </GeneList>
          <Name>AIFM1, 3-BP DEL, 601AGA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 601AGA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300169.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32536" TraitType="Disease" MappingType="Name" MappingValue="COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6" MappingRef="Preferred">
        <MedGen CUI="C3151753" Name="Severe X-linked mitochondrial encephalomyopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

